NEW YORK, Dec. 17 – British structural genomics company Astex Technology said Monday it raised 5.7 million pounds ($8.1 million) in its second round of private financing this year. 

Previous investors in Astex, including Abingworth, Advent International, Alta Partners, GIMV, and Oxford Bioscience Partners, participated in the round. 

The Cambridge-based company said it would use the funds to develop its structure-based drug discovery technologies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.